News | 19/11/2026
INTERNATIONAL RECOGNITION  

Marion Subklewe Named Once Again Among the “Highly Cited Researchers”

The director of the MCCG is among the researchers whose work is most frequently cited in the scientific community worldwide.
Prof. Dr. med. Marion Subklewe, Director of the Munich Center for Cell and Gene Therapy (MCCG) at LMU Medical Center, is among the “Highly Cited Researchers 2026.” The analytics firm Clarivate published the list on November 18. This marks Subklewe’s third consecutive appearance on the list. She is listed in the “Cross-Field” category, in which Clarivate recognizes researchers whose work is widely cited across multiple disciplines.
 Prof. Dr. med. Marion Subklewe, Director of the MCCG—Munich Center for Cell and Gene Therapy at LMU University Hospital Munich

Subklewe conducts research at the LMU Gene Center and at the Department of Medicine III on immunotherapy using CAR-T cells and T-cell engagers. These methods are used in hematology and oncology and, increasingly, in the treatment of autoimmune diseases. With the MCCG, which Subklewe heads, the LMU Medical Center established a center in 2026 that brings this work together across disciplinary boundaries.

A total of 20 LMU researchers are on this year’s list—more than ever before. “What a success for LMU!” said LMU President Prof. Dr. Matthias Tschöp.


Highly Cited Researchers

Clarivate operates the Web of Science literature and citation database and has published the list annually since 2001. The evaluation covers publications from the past eleven years—for 2026, that is, the years 2015 through 2025. Only works that rank among the top 1 percent of the most-cited in their field and year of publication are included. The 2026 edition lists 6,802 researchers from 62 countries.


Further information

LMU press release dated November 18, 2026

Prof. Dr. med.  Marion Subklewe

 Director of the MCCG – Munich Center for Cell and Gene Therapy 

Originally translated with DeepL